Magaldrate PCD Pharma Franchise Company
Cafoli Lifecare is a reliable Magaldrate PCD pharma franchise company in India, offering 6 Magaldrate formulations manufactured at WHO-GMP certified facilities. The range is supplied in suspension and syrup form — the presentations that dominate real-world antacid prescribing at the retail counter.
What is Magaldrate?
Magaldrate is a hydroxymagnesium aluminate antacid that neutralises gastric acid and raises intragastric pH, providing rapid symptomatic relief. It is typically combined with simethicone, an antifoaming agent that helps disperse trapped gas. It is indicated for hyperacidity, heartburn and associated flatulence. Compound details are available on PubChem.
Therapeutic Applications
Magaldrate suspensions are used for hyperacidity and acid dyspepsia, heartburn and gastro-oesophageal reflux symptoms, gastritis, and symptomatic relief of flatulence and bloating when combined with simethicone. It is prescribed by gastroenterologists, general physicians, general surgeons and consulting practitioners across almost every specialty.
Why Magaldrate is a High-Potential Molecule for Distributors
Antacid suspensions have an unusual commercial profile: they are prescribed almost universally as add-on therapy alongside NSAIDs, antibiotics and steroids, which means Magaldrate rides along with a large share of every other prescription written in a territory. Onset of relief is immediate and patient-perceptible, which drives strong brand loyalty and chemist-level counter recommendation — repeat sales often continue without a fresh prescription. For a distributor, this makes it a dependable volume-anchoring line that keeps stock turning even in months when specialty products move slowly.
Why Choose Cafoli Lifecare
Cafoli Lifecare offers exclusive monopoly rights across your chosen territory, WHO-GMP certified and DCGI-approved manufacturing, consistent stock availability, competitive margins, and complete promotional inputs including visual aids, samples, MR bags, catch covers and reminder cards. We support a network of 1000+ franchise partners across India.
References
- PubChem — Magaldrate Compound Summary, National Library of Medicine
- PubMed — Clinical literature on Magaldrate
Our formulations of Magaldrate find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: